Literature DB >> 27237075

TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-/-) mice.

Siva Sankara Vara Prasad Sakamuri1, Yusuke Higashi1, Sergiy Sukhanov1, Jalahalli M Siddesha1, Patrice Delafontaine1, Ulrich Siebenlist2, Bysani Chandrasekar3.   

Abstract

BACKGROUND AND AIMS: Atherosclerosis is a major cause of heart attack and stroke. Inflammation plays a critical role in the development of atherosclerosis. Since the cytoplasmic adaptor molecule TRAF3IP2 (TRAF3-Interacting Protein 2) plays a causal role in various autoimmune and inflammatory diseases, we hypothesized that TRAF3IP2 mediates atherosclerotic plaque development.
METHODS: TRAF3IP2/ApoE double knockout (DKO) mice were generated by crossing TRAF3IP2(-/-) and ApoE(-/-) mice. ApoE(-/-) mice served as controls. Both DKO and control mice were fed a high-fat diet for 12 weeks. Plasma lipids were measured by ELISA, atherosclerosis by en face analysis of aorta and plaque cross-section measurements at the aortic valve region, plaque necrotic core area, collagen and smooth muscle cell (SMC) content by histomorphometry, and aortic gene expression by RT-qPCR.
RESULTS: The plasma lipoprotein profile was not altered by TRAF3IP2 gene deletion in ApoE(-/-) mice. While total aortic plaque area was decreased in DKO female, but not male mice, the plaque necrotic area was significantly decreased in DKO mice of both genders. Plaque collagen and SMC contents were increased significantly in both female and male DKO mice compared to respective controls. Aortic expression of proinflammatory cytokine (Tumor necrosis factor α, TNFα), chemokine (Chemokine (C-X-C motif) Ligand 1, CXCL1) and adhesion molecule (Vascular cell adhesion molecule 1, VCAM1; and Intercellular adhesion molecule 1, ICAM1) gene expression were decreased in both male and female DKO mice. In addition, the male DKO mice expressed markedly reduced levels of extracellular matrix (ECM)-related genes, including TIMP1 (Tissue inhibitor of metalloproteinase 1), RECK (Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs) and ADAM17 (A Disintegrin And Metalloproteinase 17).
CONCLUSIONS: TRAF3IP2 plays a causal role in atherosclerotic plaque development and vulnerability, possibly by inducing the expression of multiple proinflammatory mediators. TRAF3IP2 could be a potential therapeutic target in atherosclerotic vascular diseases.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Act1; Atherosclerosis; CIKS; Collagen; Plaque stability; TRAF3IP2

Mesh:

Substances:

Year:  2016        PMID: 27237075      PMCID: PMC5035578          DOI: 10.1016/j.atherosclerosis.2016.05.029

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  46 in total

1.  OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators.

Authors:  Anthony J Valente; Anand M Irimpen; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Free Radic Biol Med       Date:  2014-02-20       Impact factor: 7.376

2.  Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.

Authors:  B Schieffer; E Schieffer; D Hilfiker-Kleiner; A Hilfiker; P T Kovanen; M Kaartinen; J Nussberger; W Harringer; H Drexler
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

Review 3.  The paradoxical role of IL-17 in atherosclerosis.

Authors:  Fangchen Gong; Zhengxia Liu; Jingning Liu; Ping Zhou; Ying Liu; Xiang Lu
Journal:  Cell Immunol       Date:  2015-05-29       Impact factor: 4.868

4.  Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium.

Authors:  Zhe Zhou; Pallavi Subramanian; Gueler Sevilmis; Brigitta Globke; Oliver Soehnlein; Ela Karshovska; Remco Megens; Kathrin Heyll; Jerold Chun; Jean Sébastien Saulnier-Blache; Markus Reinholz; Marc van Zandvoort; Christian Weber; Andreas Schober
Journal:  Cell Metab       Date:  2011-05-04       Impact factor: 27.287

5.  Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms.

Authors:  Joseph J Boyle; Peter L Weissberg; Martin R Bennett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-17       Impact factor: 8.311

6.  Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.

Authors:  Ralph Gareus; Elena Kotsaki; Sofia Xanthoulea; Ingeborg van der Made; Marion J J Gijbels; Rozina Kardakaris; Apostolos Polykratis; George Kollias; Menno P J de Winther; Manolis Pasparakis
Journal:  Cell Metab       Date:  2008-11       Impact factor: 27.287

7.  Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-beta-activated protein kinase 1 binding protein 1 beta/p38 alpha mitogen-activated protein kinase signaling cascade.

Authors:  Wataru Matsuyama; Michel Faure; Teizo Yoshimura
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

8.  Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.

Authors:  Caini Liu; Wen Qian; Youcun Qian; Natalia V Giltiay; Yi Lu; Shadi Swaidani; Saurav Misra; Li Deng; Zhijian J Chen; Xiaoxia Li
Journal:  Sci Signal       Date:  2009-10-13       Impact factor: 8.192

9.  TNFalpha-induced macrophage death via caspase-dependent and independent pathways.

Authors:  Tri M Tran; Vladislav Temkin; Bo Shi; Lisa Pagliari; Soizic Daniel; Christiane Ferran; Richard M Pope
Journal:  Apoptosis       Date:  2009-03       Impact factor: 4.677

10.  CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.

Authors:  Anthony J Valente; Robert A Clark; Jalahalli M Siddesha; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2012-04-26       Impact factor: 5.000

View more
  8 in total

1.  TRAF3IP2 (TRAF3 Interacting Protein 2) Mediates Obesity-Associated Vascular Insulin Resistance and Dysfunction in Male Mice.

Authors:  Zachary I Grunewald; Francisco I Ramirez-Perez; Makenzie L Woodford; Mariana Morales-Quinones; Salvador Mejia; Camila Manrique-Acevedo; Ulrich Siebenlist; Luis A Martinez-Lemus; Bysani Chandrasekar; Jaume Padilla
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

2.  RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferation.

Authors:  Srinivas Mummidi; Nitin A Das; Andrea J Carpenter; Tadashi Yoshida; Manjunath Yariswamy; Ricardo Mostany; Reza Izadpanah; Yusuke Higashi; Sergiy Sukhanov; Makoto Noda; Ulrich Siebenlist; Randy S Rector; Bysani Chandrasekar
Journal:  J Cell Physiol       Date:  2019-05-09       Impact factor: 6.384

Review 3.  The Role of ADAM17 in Inflammation-Related Atherosclerosis.

Authors:  Bai-Yi Tang; Jin Ge; Yang Wu; Juan Wen; Xiao-Hong Tang
Journal:  J Cardiovasc Transl Res       Date:  2022-06-01       Impact factor: 4.132

4.  Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction.

Authors:  Manjunath Yariswamy; Tadashi Yoshida; Anthony J Valente; Hemanth Kumar Kandikattu; Siva S V P Sakamuri; Jalahalli M Siddesha; Sergiy Sukhanov; Zubaida Saifudeen; Lixin Ma; Ulrich Siebenlist; Jason D Gardner; Bysani Chandrasekar
Journal:  J Biol Chem       Date:  2016-07-27       Impact factor: 5.157

5.  The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.

Authors:  Sergiy Sukhanov; Yusuke Higashi; Tadashi Yoshida; Srinivas Mummidi; Annayya R Aroor; Jacob Jeffrey Russell; Shawn B Bender; Vincent G DeMarco; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2020-11-04       Impact factor: 4.850

6.  Effects of Cervical Rotatory Manipulation (CRM) on Carotid Atherosclerosis Plaque in Vulnerability: A Histological and Immunohistochemical Study Using Animal Model.

Authors:  Ji Qi; Ruiyue Ping; Shaoqun Zhang; Yanxiao Xu; Kai Wu; Yikai Li
Journal:  Biomed Res Int       Date:  2019-02-04       Impact factor: 3.411

7.  Knockdown of TRAF3IP2 suppresses the expression of VEGFA and the proliferation of keratinocytes and vascular endothelial cells.

Authors:  Yali Song; Lamei Chen; Yuanyuan Li; Qingxia Lin; Wenmin Liu; Li Zhang
Journal:  Heliyon       Date:  2019-05-08

8.  MiR-32-3p Regulates Myocardial Injury Induced by Microembolism and Microvascular Obstruction by Targeting RNF13 to Regulate the Stability of Atherosclerotic Plaques.

Authors:  Dajun Huang; Yang Liu; Le Gao; Xiaomin Wei; Yuli Xu; Ruping Cai; Qiang Su
Journal:  J Cardiovasc Transl Res       Date:  2021-06-29       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.